BI 894416

DRUG6 trials

Sponsors

Boehringer Ingelheim

Conditions

AsthmaHealthy

Phase 1

This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated

CompletedNCT03315936

Boehringer IngelheimHealthy

Start: 2017-11-02End: 2018-09-10Updated: 2024-03-18

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood

CompletedNCT03722173

Boehringer IngelheimHealthy

Start: 2018-11-13End: 2018-12-18Updated: 2023-08-14

A Study in Healthy Men to Test Whether Food Affects the Amount of BI 894416 in the Blood

CompletedNCT03871595

Boehringer IngelheimHealthy

Start: 2019-03-20End: 2019-04-24Updated: 2023-08-14

Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

CompletedNCT03971539

Boehringer IngelheimAsthma

Start: 2019-07-15End: 2020-10-26Updated: 2023-08-21

A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood

CompletedNCT04060719

Boehringer IngelheimHealthy

Start: 2019-09-04End: 2019-10-17Updated: 2023-08-14

A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated

TerminatedNCT04540874

Boehringer IngelheimHealthy

Start: 2020-10-05End: 2020-11-12Updated: 2023-08-16